Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Software Integration and Validation (Ardia Platform & BioPharma Finder)

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541512
New
Utilization Management Technical Solutions RFI
Solicitation # utilization-management-technical-solutions-rfi
Noridian Healthcare Solutions, LLC is issuing a Request for Information (RFI) to identify qualified technology providers and strategic partners capable of delivering configurable technical solutions for end-to-end utilization management (UM) workflows. The primary objective is to modernize the evaluation of medical necessity, appropriateness of care, provider compliance, and program integrity for federal and state healthcare programs. The scope of the RFI covers a wide range of capabilities, including clinical operations such as intake, prior authorization, and appeals, as well as workflow automation, provider engagement portals, data interoperability using HL7, FHIR, and X12 standards, and the integration of AI and advanced intelligence. This opportunity is open to a broad range of small business entities, including SDB, WOSB, HUBZone, VOSB, and SDVOSB certifications, under NAICS code 541512. Interested respondents must notify Noridian via email to gain access to the Agiloft Contract Management System, where all official correspondence and submissions must be conducted. Responses are required to be submitted using a specific templated spreadsheet by September 21, 2026. Following a comprehensive review of the submissions, Noridian may invite selected respondents to participate in solution demonstrations during the fourth quarter of 2026. Respondents must certify that they are not debarred or suspended and have no conflicts of interest that would prohibit contracting with Noridian.
Noridian Healthcare Solutions, LLC

POSTED

about 8 hours ago

DEADLINE

in 9 days

AI Contract Overview

Show more

The contract requires the integration of an LC-MS system with the Ardia Platform and the validation of BioPharma Finder software to ensure full compliance with FDA workflows and the MAT list requirements. This effort is critical for enabling seamless data flow and regulatory alignment in bioanalytical applications, particularly within pharmaceutical and biotech environments governed by stringent federal standards. The work must be performed at the designated place of performance in Saint Louis, Missouri, with strict adherence to validation protocols that meet FDA expectations for software reliability and data integrity. The solicitation is classified as a subcontract under a Total Small Business Set-Aside, meaning only small businesses certified by the SBA are eligible to respond. It falls under NAICS code 541512, indicating it pertains to computational services and software development for scientific and technical purposes. The opportunity was posted on May 6, 2026, with a response deadline of May 7, 2026, at 4:00 PM, reflecting a narrow window for submission. The contracting entity is the FDA Office of Acquisition and Grant Services, operating under the Department of Health and Human Services, underscoring the importance of regulatory compliance and alignment with federal health agency objectives.

General Info

Integrate LC-MS with Aridia Platform, validate BioPharma Finder software for FDA compliance in Saint Louis.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

541512 - Computer Systems Design ServicesView NAICS

Place of Performance

Saint Louis, MO, 63110, USA

Set-Aside

SBA

Documents

This scope was carved out of 75F40126Q00088.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

Orbitrap Excedion Pro BioPharma Mass Spectrometer and UHPLC

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Integration of the LC-MS system with the Ardia Platform and validation of BioPharma Finder software to ensure compliance with FDA workflows and MAT list requirements.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS